Randomised double blind controlled trial of cyclosporin in multiple sclerosis. - Wikidata - awgldk - TriplyDB

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

http://www.wikidata.org/entity/Q30495856

about

Effect of cyclosporine on blood pressure Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments Recent developments in drug therapy for multiple sclerosis.Total lymphoid irradiation in multiple sclerosis A placebo-controlled trial of isoprinosine in patients with multiple sclerosis Immunotherapy for multiple sclerosis.Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.Combinations of drugs.Investigational drug therapies of treatment of multiple sclerosis.Introductory remarks: immunosuppressive and immunomodulating drugs, where and how do they act?Recent advances in the pharmacological control of experimental allergic encephalomyelitis (EAE) and the implications for multiple sclerosis treatment.Current immunotherapy in multiple sclerosis.T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells.Prospects for the treatment of multiple sclerosis.

P2860

Q24240463-59E66746-AA2E-4665-A486-CDF27356A3E8 Q26851694-7D6D81A0-0856-486E-83A7-B25B523943A4 Q33639891-2436D49D-619F-4B2E-8B51-5AAE8F15E467 Q33731206-D648ED5D-E211-43CA-9E7B-5040AC5F6855 Q33731211-C71DD235-98C7-47A9-89A2-5672D635A206 Q36850073-2ACE5E07-8BFC-4FCA-916E-F59F24DEF3BF Q37122279-04E10246-0BAA-4669-9CC0-2A9FC49DAD80 Q40933997-52FB7171-D055-4981-AA88-033718757236 Q41622019-A218A6DD-D1CD-498A-A71B-AAF036CFD25D Q41622065-889B241F-B6F8-4F1F-A2C6-040F49732982 Q41622161-1610F918-5DE7-4320-AB6C-5E83880EFF9F Q41745131-1EF4D381-73CF-4327-B40D-9A3C0552F2B1 Q41993810-7B01C8EC-B26C-4735-9BEB-D5A14CA28B32 Q55001673-05C0A9B5-DF50-4066-B5D9-87E01DBA218A

P2860

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

http://www.wikidata.org/entity/Q30495856

description

1989 nî lūn-bûn

@nan

1989 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

@ast

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

@en

type

label

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

@ast

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

@en

prefLabel

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

@ast

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

@en

P1433

Q30495856-07CB9080-F744-4CE6-94CB-4233005ED214

P1476

Q30495856-A5161188-CE83-44F0-90CC-6C626E92212E

P2093

Q30495856-0463AEB3-D7D1-4E9B-A1B6-FA343409098C

Q30495856-24AE830D-A7CE-46BF-8BA4-7D04DCBE9DD5

Q30495856-2DBDDAC8-C18E-4EBD-8701-F5211D9460A1

Q30495856-5E6DF950-9DED-49FF-8AD7-1D7772FC2797

Q30495856-97B64BAE-9DE6-4E0F-B258-3E1D38F5A8D7

Q30495856-9B64DEC7-6FD0-4F11-B45C-1C60D3967D90

Q30495856-CD101723-CBED-416E-8757-073DEA99D9F3

Q30495856-CFE23192-355E-4250-A3C5-B80D053DF3FD

Q30495856-E18A747C-4576-4A4E-BD3D-9E4B921A27CA

Q30495856-EED0FD13-5EB2-40ED-9AA5-BC2C67D0B9B2

P2860

Q30495856-40FDA167-D0B7-4614-A787-64101818AB73

Q30495856-7A6D38A5-8B32-4941-8CFC-9DBC00E8C092

Q30495856-9B318021-21E0-4F77-AEFB-D6BE81C9E7A3

Q30495856-9E07E40E-22B3-4B47-9928-F3EA73D12C77

Q30495856-C2A939F9-5687-4C06-9AA0-376B1C74F0BE

Q30495856-CB114A2F-58A3-43FE-8B80-ED5A896CBE45

Q30495856-D873F5C3-F49A-426A-8CDA-C14F85861429

Q30495856-FF9B459D-C87D-4B1E-980B-ECF7C2C4CBBB

P304

Q30495856-D707D42A-166C-4BAE-8DEF-B68B757E4982

P31

Q30495856-041881E2-453F-4A63-84CF-B7901173387C

P356

Q30495856-65BA6D82-1A92-4316-8C41-7E5EF07052C2

P407

Q30495856-1D4ED323-56FD-45D2-A614-E0728CE9067B

P433

Q30495856-CF673EC6-0D97-4151-A2AB-1560F6392FD0

P478

Q30495856-3298271E-F8AD-4FD0-BFA6-28BC6E57D203

P577

Q30495856-2E29E59C-D335-44D7-BD94-EC9621604BD0

P5875

Q30495856-037390E0-7597-4338-BC8E-60AE285A66DD

P698

Q30495856-FFEECEF8-F9EA-4F31-973C-F26F3784586D

P932

Q30495856-0EFBEB73-82B4-417C-8864-A6BC8652D88D

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

@en

P2093

Clifford Jones R

http://www.w3.org/2001/XMLSchema#string

Harrison J

http://www.w3.org/2001/XMLSchema#string

Koetsier JC

http://www.w3.org/2001/XMLSchema#string

Mellein B

http://www.w3.org/2001/XMLSchema#string

Mertin J

http://www.w3.org/2001/XMLSchema#string

Mispelblom Beyer JO

http://www.w3.org/2001/XMLSchema#string

Poole T

http://www.w3.org/2001/XMLSchema#string

Robinson K

http://www.w3.org/2001/XMLSchema#string

Rudge P

http://www.w3.org/2001/XMLSchema#string

Van Walbeek HK

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.

Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses.

Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients.

Chronic relapsing experimental allergic encephalomyelitis: cyclosporin-A treatment of relapsing and remitting disease.

Visual evoked response in diagnosis of multiple sclerosis.

Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis.

P304

559-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.52.5.559

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

1989-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20495957

http://www.w3.org/2001/XMLSchema#string

P698

2659736

http://www.w3.org/2001/XMLSchema#string

P932

1032160

http://www.w3.org/2001/XMLSchema#string